BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 7, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 20, 1997
View Archived Issues
Avax evaluates its ovarian cancer vaccine in phase II
Read More
Promising preliminary phase II data reported for VX-478/141W94
Read More
PharmaPrint and AHP to collaborate on herbal products
Read More
Clinical results reported for 546C88 in septic shock
Read More
ImClone and CombiChem enter alliance for drug discovery in oncology
Read More
Schering-Plough: Q3 1997 highlights
Read More
Synthelabo: Q3 1997 highlights
Read More
Prodrugs of selective COX-2 inhibitors
Read More
Warner-Lambert prepares new cyclic amino acids related to gabapentin
Read More
BASF prepares anti-hTNF-alpha antibodies
Read More
Two large trials support use of alteplase accelerated infusion for acute MI
Read More
Shire files IND for new formulation of aciclovir
Read More
Peptech and Allergan terminate collaboration on GMDP
Read More
Cefluprenam: basic and clinical research on new injectable cephalosporin
Read More
Effects of 5-HT, TxA2 and their antagonists on restenosis
Read More
Andrx's Diltia XT approved and launched in U.S.
Read More
Alpharma will distribute PerioGlas in key European markets
Read More
FDA approves RPR's Nasacort for pediatric use
Read More
New cell therapy company to be formed by VIMRx and Baxter
Read More
Peptech reaches phase I goals for antagonist G; exercises license option
Read More
Products under development at Meiji Seika
Read More
Advisory panel to the FDA unanimously recommends PDL's Zenapax
Read More
Toyama to begin U.S. development of Alzheimer's drug
Read More
Peripheral and Central Nervous System Drugs Advisory Committee meets next month
Read More
U.S. testing of Toyama antiarthritic to begin soon
Read More
Anti-Infective Drugs Advisory Committee to discuss three NDAs
Read More
Viragen considers genital herpes as possible target for Omniferon
Read More
Australian government awards Cortecs grant for otitis media research
Read More
